Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors (CoVaCheck) A Multicenter Retrospective Cohort Analysis in Austria

NCT07341321 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT07341321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07341321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors (CoVaCheck) A Multicenter Retrospective Cohort Analysis in Austria
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2026
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

checkpoint inhibitor, hepatocellular carcinoma, mrna vaccination